This Week in PLOS

As they report in PLOS One, the National Cancer Institute's Yves Pommier and colleagues from the US and Brazil brought together whole-exome sequence data with pharmacological response profiles for the NCI-60 collection, a set of publicly available cancer cell lines from nine tissues of origin.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.